Spanish Version of Credibility and Expectancy Questionnaire in Patients With Musculoskeletal Injuries

December 26, 2025 updated by: Silvia Lahuerta Martín, University of Valladolid

Translation, Adaptation and Valitation of the Spanish Version of Credibility and Expectancy Questionnaire in Patiens With Musculoskeletal Injuries

Physiotherapy treatment of musculoskeletal injuries should be performed following the main clinical guidelines of person-centered care. Patients' perception of the abilities and facilities provided by physiotherapists boost a convenient therapeutic relationship. This relation is linked with more satisfaction and adherence during the treatment, as well as credibility and expectancy of the patient related to the treatment. Thus, Credibility and Expectancy questionnaire is normally used to assess that point. CEQ presents good psychometric properties when used in Physisiotherapy interventions, but there is not a spanish version of this questionaire.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

76

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Soria, Spain, 42004
        • Silvia Lahuerta Martín

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients who are going to start physiotherapy treatment due to musculoskeletal injuries.

Description

Inclusion Criteria:

  • Volunteer patients who are going to start physiotherapy treatment due to musculoskeletal injuries.
  • Age above 18 years old.
  • Understanding of the study purpose and signing the informed consent.

Exclusion Criteria:

  • Patients with cognitive deprivation.
  • Not able to fill in the questionnaires autonomously.
  • Mother tongue different from Spanish.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CEQ Validation
In initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session.
Other: Validation CEQ
In initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Content validity
Time Frame: During the intervention: Session 1
Credibility and Expectancy questionnaire (CEQ) must be completed, while registering the time used and the quality and the reading comprehension.
During the intervention: Session 1
Structural validity
Time Frame: During the intervention: session 1 and 2 treatment
Exploratory factor analysis (EFA) and confirmatory factorial analysis (CFA) were performed. For EFA Kaiser criterion >0.70 will be acceptable. For CFA, goodness of fit index and comparative fit index were calculated, where values up to 0.90 were acceptable.
During the intervention: session 1 and 2 treatment
Reliability
Time Frame: During the intervention.
Credibility and Expectancy questionnaire (CEQ) reliability will be analised through internal consistency (alpha Cronbach > 0.70 recomended)) and test-retest (intraclass correlation coeficient >0.70 acceptable).
During the intervention.
Hypotheses testing for construct validity
Time Frame: During the intervention.
Comparing CEQ with other measurement instruments.
During the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Valladolid

Investigators

  • Principal Investigator: Silvia Lahuerta Martín, University of Valladolid, Soria, Spain

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2024

Primary Completion (Actual)

July 15, 2024

Study Completion (Actual)

December 4, 2024

Study Registration Dates

First Submitted

December 18, 2023

First Submitted That Met QC Criteria

February 12, 2024

First Posted (Actual)

February 15, 2024

Study Record Updates

Last Update Posted (Actual)

December 31, 2025

Last Update Submitted That Met QC Criteria

December 26, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • PI 23-3405

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Validation Study

Clinical Trials on Validation CEQ

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe